The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Congressionally Directed Medical Research Programs (CDMRP) -- Gulf War Illness Research Program -- Research Advancement Award
The FY19 GWIRP Research Advancement Award supports applied research in GWI that is aimed at continued expansion and validation of markers and treatments that are supported by evidence in the GWI field. The Research Advancement Award targets the Qualification phase of the research pipeline as outlined in Section II.A.2.
Preliminary Data: Inclusion of preliminary data in the field of GWI and other supporting information is required. The project should include a well-formulated, testable hypothesis based on existing evidence in the GWI field that holds translational potential.
Impact: Applications must articulate how results will lead to a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome. All applications must focus on features of GWI and Veterans of the 1990-1991 Gulf War affected by GWI. It is the responsibility of the Principal Investigator (PI) to clearly and explicitly articulate the project’s potential impact on GWI.
• Required Pre-Application Deadline: July 12, 2019
• Application Submission Deadline: October 3, 2019
Areas of Interest
Considering the current Gulf War Illness Landscape and the GWIRP’s mission, all FY19 GWIRP applications must address at least one of the following overarching challenges unless adequate justification for exception is provided.* • Revolutionize treatment and minimize negative side effects • Eliminate the health consequences associated with Gulf War Illness (GWI) • Distinguish symptom clusters to better target treatments • Identify what drives GWI and determine how to intervene • Identify why GWI is worse for some Veterans than for others • Validate determinants of GWI susceptibility, latency, and impacts on organs and systems • Better define and diagnose GWI • Determine whether GWI puts Veterans at greater risk for developing neurological diseases, cancers, or other serious conditions • Help Veterans, their caregivers, and clinicians communicate effectively about GWI, its symptoms, and potential treatments • Primary prevention strategies based on a consistent theory of GWI etiology
Independent investigators at all academic levels (or equivalent) are eligible to apply.
The anticipated direct costs budgeted for the entire period of performance for an FY19 GWIRP Research Advancement Award will not exceed $700,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. If applying under the Biorepository Contribution Option, direct costs will not exceed $720,000.